Wistar Institute Researchers Design Novel Immunotherapy for Brain Cancer
December 04, 2024
December 04, 2024
PHILADELPHIA, Pennsylvania, Dec. 4 (TNSres) -- The Wistar Institute issued the following news release:
* * *
Trispecific Design Controls Glioblastoma Tumors in Preclinical Models
* * *
The Wistar Institute's David B. Weiner, Ph.D. -- Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable Trust Distinguished Professor in Cancer Research -- and his lab have successfully tested a new immune therapy t . . .
* * *
Trispecific Design Controls Glioblastoma Tumors in Preclinical Models
* * *
The Wistar Institute's David B. Weiner, Ph.D. -- Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable Trust Distinguished Professor in Cancer Research -- and his lab have successfully tested a new immune therapy t . . .